KATHY WILLENBORG: Open Payments
NPI 1760770085 · ANNA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,188 in 70 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $375 · 2025 $1,188
Food & beverage: $1,188
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $260 |
| Alkermes, Inc. | 14 | $256 |
| E.R. Squibb & Sons, L.L.C. | 12 | $207 |
| Otsuka America Pharmaceutical, Inc. | 9 | $150 |
| Janssen Pharmaceuticals, Inc | 8 | $137 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| Teva Pharmaceuticals USA, Inc. | 3 | $45 |
| Neurocrine BioSciences, Inc. | 2 | $42 |
| Lundbeck LLC | 2 | $28 |
Products named: VRAYLAR, ARISTADA, COBENFY, REXULTI, SPRAVATO, CAPLYTA, INVEGA SUSTENNA, INGREZZA.
Industry payments across IL — which companies pay providers there.
